
Human Serine/threonine-protein kinase PLK1 415-422, YSDKYGLGY
Description
About Human Serine/threonine-protein kinase PLK1 415-422, YSDKYGLGY
The Human Serine/threonine-protein kinase PLK1 Peptide (IEDB: 163983) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Serine/threonine-protein kinase Peptide, H-YSDKYGLGY-OH (Uniprot: P53350 aa: 415-422) from JPT is produced under strict quality control and quality management.
Human Serine/threonine-protein kinase PLK1 415-422, YSDKYGLGY - Specifications
- Peptide sequence: H-YSDKYGLGY-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Serine/threonine-protein kinase PLK1 415-422, YSDKYGLGY
References:
Read References with JPT’s Antigen Peptides
Human Serine/threonine-protein kinase PLK1 415-422, YSDKYGLGY has been described in:
MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements, nan, 2012 (PMID: Submission)
A comprehensive analysis of peptides presented by HLA-A1., Tissue Antigens, 2015 (PMID: 25880248)
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases., Cell Rep Med, 2021 (PMID: 33521695)
Documentation
Documentation for Human Serine/threonine-protein kinase PLK1 415-422, YSDKYGLGY
Properties
Properties of Human Serine/threonine-protein kinase PLK1 415-422, YSDKYGLGY
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Serine/threonine-protein kinase |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Serine/threonine-protein kinase PLK1 415-422, YSDKYGLGY
Information | Values |
---|---|
Sequence: | H-YSDKYGLGY-OH |
Specifications: | 9mer peptide as TFA salt |